Pamela Bradley
Psychiatric/Mental Health · Longview, TXNPI 1437938495
Payments from drug & device makers
Across 308 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$831
- AbbVie$443
- Vanda Pharmaceuticals Inc.$417
- E.r. Squibb & Sons, L.L.C.$385
- plus $1K from 11 others
What the payments were for
- Food & beverage$6,308100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 56 | $1,529 |
| Teva Pharmaceuticals USA, Inc. | 74 | $1,316 |
| Alkermes, Inc. | 49 | $831 |
| AbbVie | 27 | $443 |
| Vanda Pharmaceuticals Inc. | 25 | $417 |
| E.r. Squibb & Sons, L.L.C. | 17 | $385 |
| Otsuka America Pharmaceutical, Inc. | 14 | $342 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $278 |
| Johnson & Johnson | 8 | $165 |
| Indivior Inc. | 7 | $149 |
| Gilead | 2 | $134 |
| Lundbeck LLC | 6 | $116 |
| Noven Therapeutics, LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Noven Pharmaceuticals, Inc. | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,320 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 40 | $438,347 |
| IngrezzaValbenazine Tosylate | 46 | $384,556 |
| UzedyRisperidone | 43 | $164,857 |
| LybalviOlanzapine/Samidorphan Malate | 29 | $47,673 |
| VraylarCariprazine Hcl | 17 | $26,700 |
| TrintellixVortioxetine Hydrobromide | 23 | $12,082 |
| Doxepin Hcl | 12 | $4,491 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $2,156 |
| Divalproex Sodium | 27 | $1,910 |
| Quetiapine Fumarate | 61 | $1,630 |
| Oxcarbazepine | 16 | $1,230 |
| Guanfacine Hcl ErGuanfacine Hcl | 23 | $897 |
| Aripiprazole | 34 | $860 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 14 | $804 |
| Buspirone Hcl | 32 | $711 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Uzedy | $1,316 | $603,20483 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,529 | $384,55646 claims |
| Alkermes, Inc.Lybalvi | $831 | $47,67329 claims |
| AbbVieVraylar | $443 | $26,70017 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $25 | $12,08223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Longview
- Tracy HicksLongview$684K
- Tracy TaylorLongview$14K
- Wendy RogersLongview$13K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.